BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36142445)

  • 21. [Expression of Ether à go-go 1 and its molecular mechanism of regulating the malignant phenotype of osteosarcoma].
    Chen ZD; Liu QJ; Zeng WR; Wu XY; Lin B; Wu J
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):818-825. PubMed ID: 27998439
    [No Abstract]   [Full Text] [Related]  

  • 22. Frequent aberrant expression of the human ether à go-go (hEAG1) potassium channel in head and neck cancer: pathobiological mechanisms and clinical implications.
    Menéndez ST; Villaronga MA; Rodrigo JP; Alvarez-Teijeiro S; García-Carracedo D; Urdinguio RG; Fraga MF; Pardo LA; Viloria CG; Suárez C; García-Pedrero JM
    J Mol Med (Berl); 2012 Oct; 90(10):1173-84. PubMed ID: 22466864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of hEAG1 potassium channels by arachidonic acid.
    Gavrilova-Ruch O; Schönherr R; Heinemann SH
    Pflugers Arch; 2007 Mar; 453(6):891-903. PubMed ID: 17120019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Block of HERG potassium channels by the antihistamine astemizole and its metabolites desmethylastemizole and norastemizole.
    Zhou Z; Vorperian VR; Gong Q; Zhang S; January CT
    J Cardiovasc Electrophysiol; 1999 Jun; 10(6):836-43. PubMed ID: 10376921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogens and human papilloma virus oncogenes regulate human ether-à-go-go-1 potassium channel expression.
    Díaz L; Ceja-Ochoa I; Restrepo-Angulo I; Larrea F; Avila-Chávez E; García-Becerra R; Borja-Cacho E; Barrera D; Ahumada E; Gariglio P; Alvarez-Rios E; Ocadiz-Delgado R; Garcia-Villa E; Hernández-Gallegos E; Camacho-Arroyo I; Morales A; Ordaz-Rosado D; García-Latorre E; Escamilla J; Sánchez-Peña LC; Saqui-Salces M; Gamboa-Dominguez A; Vera E; Uribe-Ramírez M; Murbartián J; Ortiz CS; Rivera-Guevara C; De Vizcaya-Ruiz A; Camacho J
    Cancer Res; 2009 Apr; 69(8):3300-7. PubMed ID: 19351862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in the K+ current-density of MCF-7 cells during progression through the cell cycle: possible involvement of a h-ether.a-gogo K+ channel.
    Ouadid-Ahidouch H; Le Bourhis X; Roudbaraki M; Toillon RA; Delcourt P; Prevarskaya N
    Recept Channels; 2001; 7(5):345-56. PubMed ID: 11697078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cis-acting element in the promoter of human ether à go-go 1 potassium channel gene mediates repression by calcitriol in human cervical cancer cells.
    Cázares-Ordoñez V; González-Duarte RJ; Díaz L; Ishizawa M; Uno S; Ortíz V; Ordoñez-Sánchez ML; Makishima M; Larrea F; Avila E
    Biochem Cell Biol; 2015 Feb; 93(1):94-101. PubMed ID: 25495694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ASTEMIZOLE, AN INHIBITOR OF ETHER-À-GO-GO-1 POTASSIUM CHANNEL, INCREASES THE ACTIVITY OF THE TYROSINE KINASE INHIBITOR GEFITINIB IN BREAST CANCER CELLS.
    García-Quiroz J; González-González ME; Díaz L; Ordaz-Rosado D; Segovia-Mendoza M; Prado-García H; Larrea F; García-Becerra R
    Rev Invest Clin; 2019; 71(3):186-194. PubMed ID: 31184333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potassium channel Ether à go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia.
    Agarwal JR; Griesinger F; Stühmer W; Pardo LA
    Mol Cancer; 2010 Jan; 9():18. PubMed ID: 20105281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of hERG and hEAG channels by Src and by SHP-1 tyrosine phosphatase via an ITIM region in the cyclic nucleotide binding domain.
    Schlichter LC; Jiang J; Wang J; Newell EW; Tsui FW; Lam D
    PLoS One; 2014; 9(2):e90024. PubMed ID: 24587194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole.
    Suessbrich H; Waldegger S; Lang F; Busch AE
    FEBS Lett; 1996 Apr; 385(1-2):77-80. PubMed ID: 8641472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Annexins A2, A6 and Fetuin-A Affect the Process of Mineralization in Vesicles Derived from Human Osteoblastic hFOB 1.19 and Osteosarcoma Saos-2 Cells.
    Bozycki L; Mroczek J; Bessueille L; Mebarek S; Buchet R; Pikula S; Strzelecka-Kiliszek A
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
    Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S
    J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapy.
    García-Quiroz J; García-Becerra R; Barrera D; Santos N; Avila E; Ordaz-Rosado D; Rivas-Suárez M; Halhali A; Rodríguez P; Gamboa-Domínguez A; Medina-Franco H; Camacho J; Larrea F; Díaz L
    PLoS One; 2012; 7(9):e45063. PubMed ID: 22984610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of bone morphogenetic proteins by osteoinductive and non-osteoinductive human osteosarcoma cells.
    Raval P; Hsu HH; Schneider DJ; Sarras MP; Masuhara K; Bonewald LF; Anderson HC
    J Dent Res; 1996 Jul; 75(7):1518-23. PubMed ID: 8876605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines.
    Taglialatela M; Pannaccione A; Castaldo P; Giorgio G; Zhou Z; January CT; Genovese A; Marone G; Annunziato L
    Mol Pharmacol; 1998 Jul; 54(1):113-21. PubMed ID: 9658196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of hEAG1 and hERG1 potassium channels by clofilium and its tertiary analogue LY97241.
    Gessner G; Heinemann SH
    Br J Pharmacol; 2003 Jan; 138(1):161-71. PubMed ID: 12522086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chloroquine inhibits tumor-related Kv10.1 channel and decreases migration of MDA-MB-231 breast cancer cells in vitro.
    Valdés-Abadía B; Morán-Zendejas R; Rangel-Flores JM; Rodríguez-Menchaca AA
    Eur J Pharmacol; 2019 Jul; 855():262-266. PubMed ID: 31082369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of HERG1 K(+) channels by the novel second-generation antihistamine mizolastine.
    Taglialatela M; Pannaccione A; Castaldo P; Giorgio G; Annunziato L
    Br J Pharmacol; 2000 Nov; 131(6):1081-8. PubMed ID: 11082114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of 25-hydroxyvitamin D3 and 1 α,25 dihydroxyvitamin D3 on differentiation and apoptosis of human osteosarcoma cell lines.
    Thompson L; Wang S; Tawfik O; Templeton K; Tancabelic J; Pinson D; Anderson HC; Keighley J; Garimella R
    J Orthop Res; 2012 May; 30(5):831-44. PubMed ID: 22042758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.